UnitedHealth Group (UNH)
313.80
-64.95 (-17.15%)
NYSE · Last Trade: May 13th, 2:50 PM EDT
Detailed Quote
Previous Close | 378.75 |
---|---|
Open | 335.74 |
Bid | 313.69 |
Ask | 313.86 |
Day's Range | 313.49 - 342.00 |
52 Week Range | 376.83 - 630.73 |
Volume | 43,042,217 |
Market Cap | 285.55B |
PE Ratio (TTM) | 13.14 |
EPS (TTM) | 23.9 |
Dividend & Yield | 8.400 (2.68%) |
1 Month Average Volume | 9,396,688 |
Chart
About UnitedHealth Group (UNH)
UnitedHealth Group is a leading diversified health and well-being company that provides a wide range of health care products and services. The company operates through two main segments: UnitedHealthcare, which offers health insurance and health services to individuals and businesses, and Optum, which delivers pharmacy care, health management, and technology solutions. UnitedHealth Group focuses on enhancing health care access, improving health outcomes, and optimizing costs through integrated care solutions and data-driven insights. With a commitment to innovation and quality, the company aims to help people live healthier lives while making the health care system work better for everyone. Read More
News & Press Releases
Shares of health insurance company UnitedHealth (NYSE:UNH)
fell 16% in the afternoon session after the company announced the unexpected departure of its CEO, Andrew Witty, for personal reasons, leading to uncertainty in leadership as former CEO Stephen Hemsley returns. Also, it suspended its full-year 2025 financial outlook, citing a continued acceleration in care activity and higher-than-anticipated medical costs, particularly within its Medicare Advantage plans.
Via StockStory · May 13, 2025
Leading securities law firm Bleichmar Fonti & Auld LLP announces that a lawsuit has been filed against UnitedHealth Group Incorporated (NYSE: UNH) and certain of the Company’s senior executives for potential violations of the federal securities laws.
By Bleichmar Fonti & Auld LLP · Via Business Wire · May 13, 2025
Wall Street's rally stretched into a second session Tuesday, fueled by improving investor sentiment after an early-week breakthrough in U.S.-China trade talks, easing inflation data and fresh geopolitical headlines involving major investment pledges from the Middle East.
Via Benzinga · May 13, 2025
Finance professional urges young professionals to engage in local volunteering Read more
Via Zexprwire · May 13, 2025
Bernie Sanders wonders if Trump is "serious about making real change rather than just issuing a press release."
Via Benzinga · May 13, 2025
UnitedHealth Group shares plunged in premarket trading as the firm announced a surprise exit of the current CEO and pulled its full-year forecast.
Via Talk Markets · May 13, 2025
U.S. stocks edged higher as April inflation cooled more than expected. Nasdaq 100 surged, led by semis and financials.
Via Benzinga · May 13, 2025
Consumer price index (CPI) rose 0.2% on a seasonally adjusted basis in April and increased 2.3% annually.
Via Stocktwits · May 13, 2025
Cox Automotive executive analyst Erin Keating said that the cost of new cars has been climbing steadily since President Trump announced auto tariffs.
Via Stocktwits · May 13, 2025
NEW YORK, May 13, 2025 (GLOBE NEWSWIRE) -- Pomerantz LLP announces that a class action lawsuit has been filed against UnitedHealth Group Incorporated (“UnitedHealth” or the “Company”) (NYSE: UNH). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, (or 888.4-POMLAW), toll-free, Ext. 7980. Those who inquire by e-mail are encouraged to include their mailing address, telephone number, and the number of shares purchased.
By Pomerantz LLP · Via GlobeNewswire · May 13, 2025
Via Benzinga · May 13, 2025
UnitedHealth CEO Andrew Witty resigns immediately; Stephen Hemsley returns as CEO and chairman as 2025 outlook is suspended due to rising costs.
Via Benzinga · May 13, 2025
UnitedHealth Stock: The Dow Jones giant warned again on medical costs and said its CEO is leaving. UNH stock plunged.
Via Investor's Business Daily · May 13, 2025
The company appointed Stephen J. Hemsley as its new chief executive officer, effective immediately.
Via Stocktwits · May 13, 2025
The consumer price index is expected to remain at 2.4% in April year-over-year, with core inflation at 2.8%.
Via Stocktwits · May 13, 2025
UnitedHealth Group (NYSE: UNH) today announced the appointment of Stephen J. Hemsley as its chief executive officer, effective immediately, following Andrew Witty’s decision to step down as CEO for personal reasons. Hemsley, who served as company CEO from 2006-2017, will remain chairman of the company’s Board of Directors and Witty will serve as a senior adviser to Hemsley.
By UnitedHealth Group · Via Business Wire · May 13, 2025
NEW YORK, May 12, 2025 (GLOBE NEWSWIRE) -- Bernstein Liebhard LLP announces that a shareholder has filed a securities class action lawsuit on behalf of investors (the “Class”) who purchased or acquired the securities of UnitedHealth Group Incorporated (“UnitedHealth” or the “Company”) (NYSE: UNH) between December 3, 2024 and April 16, 2025, inclusive.
By Bernstein Liebhard LLP · Via GlobeNewswire · May 12, 2025
Personal health and wellness is one of the many secular tailwinds for healthcare companies. But financial performance has lagged recently as players offloaded surplus COVID inventories in 2023 and 2024, a headwind for overall demand.
The result? Over the past six months, the industry has tumbled by 13%. This performance was worse than the S&P 500’s 5.5% fall.
Via StockStory · May 12, 2025
The proposal, citing a "Most Favored Nation Policy," fueled debate prompted some watchers to question the legality and feasibility of the move, while others speculated on its potential market impact.
Via Stocktwits · May 11, 2025
Via Benzinga · May 9, 2025
NEW YORK, May 09, 2025 (GLOBE NEWSWIRE) -- Pomerantz LLP announces that a class action lawsuit has been filed against UnitedHealth Group Incorporated (“UnitedHealth” or the “Company”) (NYSE: UNH). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, (or 888.4-POMLAW), toll-free, Ext. 7980. Those who inquire by e-mail are encouraged to include their mailing address, telephone number, and the number of shares purchased.
By Pomerantz LLP · Via GlobeNewswire · May 9, 2025